News from pfenex inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 01, 2015, 08:30 ET
Pfenex logo

Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value and...

Apr 30, 2015, 08:30 ET
Pfenex logo

Pfenex Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

 Pfenex Inc. (NYSE MKT: PFNX) a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value...

Apr 28, 2015, 08:30 ET
Pfenex logo

Pfenex Announces Election of John Taylor to its Board of Directors

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics and high-value and...

Apr 24, 2015, 08:30 ET
Pfenex logo

Pfenex Inc. Announces Pricing Of Follow-on Offering

 Pfenex Inc. (NYSE MKT: PFNX) a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value...

Mar 23, 2015, 09:00 ET
Pfenex logo

Pfenex Announces Early HSR Clearance for Collaboration with Hospira

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high...

Mar 16, 2015, 08:30 ET
Pfenex logo

Pfenex Reports Fourth Quarter and Full Year 2014 Results and Provides Business Update

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value and...

Mar 05, 2015, 17:00 ET
Pfenex logo

Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high...

Mar 02, 2015, 08:30 ET
Pfenex logo

Pfenex to Present at the 2015 Barclays Global Healthcare Conference

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, today announced...

Feb 27, 2015, 08:00 ET
Pfenex logo

Pfenex to Present at CALBIO 2015

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, today announced...

Feb 13, 2015, 08:30 ET
Pfenex logo

Pfenex to Present at the 2015 RBC Capital Markets' Healthcare Conference

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, today announced that it...

Feb 10, 2015, 09:15 ET

Pfenex And Hospira Announce Collaboration To Develop And Commercialize Proposed LUCENTIS® Biosimilar

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, and Hospira, Inc.,...

Jan 29, 2015, 08:00 ET
Pfenex logo

Pfenex to Present at the 17th Annual BIO CEO and Investor Conference

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, today announced...

Dec 22, 2014, 08:30 ET
Pfenex logo

Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L

 Pfenex Inc. (NYSE MKT: PFNX) today announced the IND for Px563L, Pfenex's recombinant anthrax vaccine, has been filed and is now open and that...

Nov 13, 2014, 16:05 ET
Pfenex logo.

Pfenex Reports Third Quarter 2014 Results and Provides Business Update

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value and...

Nov 06, 2014, 08:30 ET
Pfenex logo

Pfenex To Report Third Quarter 2014 Results and Provide Business Update on Thursday, November 13, 2014

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics including high value and...

Oct 09, 2014, 17:00 ET
Pfenex logo (PRNewsFoto/Pfenex)

Pfenex and PATH Partner on Vaccines

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of high-value biosimilar therapeutics and...

Oct 02, 2014, 08:00 ET
Pfenex logo (PRNewsFoto/Pfenex)

Pfenex Added to Both Russell Microcap® Index and Russell Global Indexes

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, today announced...

Oct 01, 2014, 16:05 ET
Pfenex logo (PRNewsFoto/Pfenex)

Pfenex to Present at 13th Annual BIO Investor Forum

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of high-value and difficult to manufacture proteins...

Sep 25, 2014, 08:00 ET
Pfenex logo (PRNewsFoto/Pfenex)

Pfenex Adds New Board Member

 Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of high-value and difficult to manufacture...

Sep 19, 2014, 08:30 ET
Pfenex logo (PRNewsFoto/Pfenex)

Pfenex to Present at Upcoming Industry Conference on September 26

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of high-value and difficult to manufacture proteins...